Cyclerion Therapeutics,Inc. (CYCN)
US Market

Cyclerion Therapeutics Cash flow


Cyclerion Therapeutics Cash Flow

CYCN's free cash flow for Q3 2022 was $-9.91M. For the 2022 fiscal year, CYCN's free cash flow was decreased by $37.49M and operating cash flow was $-9.91M. See a summary of the company’s cash flow.
Cash Flow
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -42.20M$ -36.52M$ -72.49M$ -102.22M$ -97.50M$ -81.22M
Investing Cash Flow
-$ 1.46M$ 18.00K$ -6.71M$ -3.44M$ -1.40M
Financing Cash Flow
$ 102.00K$ 30.79M$ 28.09M$ 211.57M$ 100.94M$ 82.62M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 145.81M$ 53.96M$ 58.23M$ 102.62M$ 0.00$ 0.00
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
-$ 30.50M$ 24.25M$ 175.00M$ 0.00-
Issuance Of Debt
-$ 0.00$ 3.51M$ 0.00--
Repayment Of Debt
Free Cash Flow
$ -42.20M$ -36.52M$ -74.01M$ -109.10M$ -100.94M$ -82.62M
Domestic Sales
Foreign Sales
Currency in USD

Cyclerion Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis